Estro-Halt EU- Designed for Estrogen Support | Contains CDG, Indole-3-Carbinol & Apigenin

Product Information

Adjuvant/completion hysterectomy after definitive CTRT and IGBT should not be performed since it does not improve survival and is associated with both increased perioperative and late morbidities [II, E]. Additional BT boost as part of adjuvant CTRT can be considered in cases with vaginal and/or parametrial positive disease (see principles of radiotherapy) [IV, B]. Previous pertinent histological exams of the cervical lesion/cancer, even if diagnosed in another institution, should be revised and integrated in the final report (eg, cone biopsy and hysterectomy specimen)

Surgical LN staging is recommended in patients with T1b1 tumor with clear margins and absence of residual tumor on imaging (including non-suspicious LN). In case of histological evidence of PLN involvement, definitive CTRT is recommended and PALND, at least up to inferior mesenteric artery, may be considered for staging purposes [III, B]. IGBT is an essential component of definitive radiotherapy and should not be replaced with an external boost (photon or proton). If BT is not available, patients should be referred to a center where this can be done [III, B]. TNM and FIGO stage, including a maximum tumor size, detailed description of extracervical tumor extension (including uterine corpus involvement) and nodal involvement (eg, total number, location, size, and metabolic activity). Last but not least, our offices are easily accessible by public transport and different training can be provided to meet a number of educational/development needs.

The specific goal of fertility-sparing surgery must be resection of invasive tumor with adequate free margins and preservation of the upper part of the cervix [IV, A]. Intraoperative frozen section is a feasible way of assessing the upper resection margin [IV, C]. In case of intraoperatively proven PLN involvement, fertility-sparing surgery should be abandoned and patients should be referred for CTRT and BT [IV, B]. PALND, at least up to inferior mesenteric artery, may be considered for staging purposes [IV, C]. Ovarian transposition cannot be recommended in N1 status [IV, D].

Coexisting precursor lesions such as squamous intraepithelial lesion/cervical intraepithelial neoplasia, adenocarcinoma in situ, stratified mucin-producing intraepithelial lesion and other pathological changes of the cervix. Para-aortic LN dissection (PALND), at least up to inferior mesenteric artery, may be considered in locally advanced cervical cancer with negative para-aortic LN on imaging for staging purposes [IV, C].

Quantum Estro Support offers natural estrogen support for women and men.* This top-tier formula contains DIM ( diinydolylmethane ), which helps promote cell cycle activity and healthy estrogen metabolism.* This formula is anchored with comprehensive botanical support in two unique blends: Fem Phyto- Support TM and Estro ProBlend TM for optimal nutritional effect. * Quantum Estro Support is a top choice nutritional formula and is highly recommended as a valuable everyday hormone support supplement.* Quantum Quality Guarantee Future-proofing radiotherapy access. The fine balance between preferences and sustainability / Our resources are limited! An insight on optimising radiotherapy resources for the future / Speed Dating / Optimal health for all together - What do staff and patients need to achieve this? / The possibility to improve patient care is endless. (Some) initiatives to integrate into radiotherapy departments of the future / Young Networking Event & Quiz (including the Elsevier Young Investigator Awards Presentation)